FGF21 and AIDS: Previous data have shown that non-AIDS comorbidities in PLWH are known to be influenced by metabolic, inflammatory, and viral factors (34–36); thus we tested markers related to such aspects, including GDF-15, suPAR, FGF-21, GLP-2, CRP, anti-CMV IgGs, and anti-EBV IgGs.